glp-1 in development Glucagon-like peptide-1 receptor: mechanisms and advances therapy Historical timeline of GLP-1 biology,

So it can cause organ damage and peripheral neuropathy, diabetic retinopathy

The full primary sequence, as published in the Sikiric laboratory's foundational work and reproduced across subsequent literature, is: Sequence (one-letter): GEPPPGKPADDAGLV Sequence (three-letter): Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Length: 15 amino acids (pentadecapeptide) Molecular weight: 1419.5 Da (monoisotopic) Molecular formula: C 62 H 98 N 16 O 22 Designation: "BPC" = Body Protection Compound

Health Monitoring Long-term success requires ongoing medical supervision to monitor metabolic health, assess cardiovascular risk factors and optimize overall wellness

Because GLP-1 effects on gastric motility may interact differently with those conditions depending on how meals and injections are coordinated, it says those patients should discuss timing with their prescriber rather than deciding alone

Adv Clin Med Res